Parexel International (ma) Corporation
Location
Massachusetts
Founded
1983-02-28
Website
Risk Signals
451 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Parexel International (ma) Corporation
Live alerts from global media, monitored by Business Radar
2024-07-25 (masslawyersweekly.com)
Corporate – Veil
Where a defendant corporation has moved to dismiss a breach of contract claim, that motion should be allowed because the plaintiff’s allegations are not enough to meet the demanding requirements for piercing the corporate veil.
Read more
2023-04-19 (masslawyersweekly.com)
Employment – Non-solicitation – Trade secrets
Where a plaintiff has moved for a preliminary injunction against a defendant former employee, that request should be denied because the plaintiff has not met its burden establishing a likelihood of success on the merits of a claim that the defendant violated the non-solicitation provision of her
Read more
2019-10-14 (xconomy.com)
Xconomy: Parexel’s Washburn Named Lyra Therapeutics Chief Medical Officer
Dana Washburn has been appointed chief medical officer of Lyra Therapeutics. Washburn comes to Watertown, MA-based Lyra from Parexel, where he was
Read more
2019-10-03 (globenewswire.com)
Parexel Appoints John Bell Executive Vice President and Chief Quality Officer
Clinical research veteran to lead Quality initiatives across global Organization in support of enhanced patient focus; appointed to company’s Executive...
Read more